Compare KALA & UCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KALA | UCL |
|---|---|---|
| Founded | 2009 | 2014 |
| Country | United States | Hong Kong |
| Employees | 6 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.5M | 40.0M |
| IPO Year | 2017 | 2019 |
| Metric | KALA | UCL |
|---|---|---|
| Price | $2.09 | $1.09 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $31.50 | N/A |
| AVG Volume (30 Days) | ★ 767.7K | 13.5K |
| Earning Date | 04-15-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 67.39 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $11.60 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $13.72 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.07 | $0.95 |
| 52 Week High | $20.58 | $4.19 |
| Indicator | KALA | UCL |
|---|---|---|
| Relative Strength Index (RSI) | 53.67 | 45.49 |
| Support Level | $0.18 | N/A |
| Resistance Level | $3.96 | $1.19 |
| Average True Range (ATR) | 0.26 | 0.08 |
| MACD | -0.12 | 0.01 |
| Stochastic Oscillator | 2.81 | 50.00 |
Kala Bio Inc is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of inventive therapies for rare and severe diseases of the front and back of the eye. It main product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
Ucloudlink Group Inc is engaged in the provision of data connectivity services and sales of Wi-Fi terminals and data-related products globally. Its uCloudlink cloud SIM platform is designed for shared mobile data connectivity services by allocating the SIM cards remotely and dynamically to users. Ucloudlink's core business is to provide mobile data connectivity services at competitive prices, which it delivers through a range of hardware products and service solutions to its business partners, retail, and enterprise customers. The main hardware terminals offered by the company include portable Wi-Fi terminals, smartphones, and smart-hardware products for international and local mobile data connectivity services. Geographically, it generates maximum revenue from Japan.